Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells

Nancy Dumont, Andrei V. Bakin, Carlos L. Arteaga

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β) is a pleiotropic growth factor that plays a critical role in modulating cell growth, differentiation, and plasticity. There is increasing evidence that after cells lose their sensitivity to TGF-β-mediated growth inhibition, autocrine TGF-β signaling may potentially promote tumor cell motility and invasiveness. To understand the molecular mechanisms by which autocrine TGF-β may selectively contribute to tumor cell motility, we have generated MDA-MB-231 breast cancer cells stably expressing a kinase-inactive type II TGF-β receptor (TβRII-K277R). Our data indicate that TβRII-K277R is expressed, can associate with the type I TGF-β receptor, and block both Smad-dependent and -independent signaling pathways activated by TGF-β. In addition, wound closure and transwell migration assays indicated that the basal migratory potential of TβRII-K277R expressing cells was impaired. The impaired motility of TβRII-K277R cells could be restored by reconstituting TGF-β signaling with a constitutively active TGF-β type I receptor (ALK5TD) but not by reconstituting Smad signaling with Smad2/4 or Smad3/4 expression. In addition, the levels of ALK5TD expression sufficient to restore motility in the cells expressing TβRII-K277R were associated with an increase in phosphorylation of Akt and extracellular signal-regulated kinase 1/2 but not Smad2. These data indicate that different signaling pathways require different thresholds of TGF-β activation and suggest that TGF-β promotes motility through mechanisms independent of Smad signaling, possibly involving activation of the phosphatidylinositol 3-kinase/Akt and/or mitogen-activated protein kinase pathways.

Original languageEnglish (US)
Pages (from-to)3275-3285
Number of pages11
JournalJournal of Biological Chemistry
Volume278
Issue number5
DOIs
StatePublished - Jan 31 2003

Fingerprint

Transforming Growth Factors
Cells
Neoplasms
Growth Factor Receptors
Cell Movement
Tumors
Chemical activation
Phosphatidylinositol 3-Kinase
Phosphorylation
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Cell growth
Growth
Mitogen-Activated Protein Kinases
Plasticity
Cell Differentiation
Assays
Intercellular Signaling Peptides and Proteins
Phosphotransferases
Breast Neoplasms

ASJC Scopus subject areas

  • Biochemistry

Cite this

Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells. / Dumont, Nancy; Bakin, Andrei V.; Arteaga, Carlos L.

In: Journal of Biological Chemistry, Vol. 278, No. 5, 31.01.2003, p. 3275-3285.

Research output: Contribution to journalArticle

@article{12ed29b481804e129db24392721378d3,
title = "Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells",
abstract = "Transforming growth factor-β (TGF-β) is a pleiotropic growth factor that plays a critical role in modulating cell growth, differentiation, and plasticity. There is increasing evidence that after cells lose their sensitivity to TGF-β-mediated growth inhibition, autocrine TGF-β signaling may potentially promote tumor cell motility and invasiveness. To understand the molecular mechanisms by which autocrine TGF-β may selectively contribute to tumor cell motility, we have generated MDA-MB-231 breast cancer cells stably expressing a kinase-inactive type II TGF-β receptor (TβRII-K277R). Our data indicate that TβRII-K277R is expressed, can associate with the type I TGF-β receptor, and block both Smad-dependent and -independent signaling pathways activated by TGF-β. In addition, wound closure and transwell migration assays indicated that the basal migratory potential of TβRII-K277R expressing cells was impaired. The impaired motility of TβRII-K277R cells could be restored by reconstituting TGF-β signaling with a constitutively active TGF-β type I receptor (ALK5TD) but not by reconstituting Smad signaling with Smad2/4 or Smad3/4 expression. In addition, the levels of ALK5TD expression sufficient to restore motility in the cells expressing TβRII-K277R were associated with an increase in phosphorylation of Akt and extracellular signal-regulated kinase 1/2 but not Smad2. These data indicate that different signaling pathways require different thresholds of TGF-β activation and suggest that TGF-β promotes motility through mechanisms independent of Smad signaling, possibly involving activation of the phosphatidylinositol 3-kinase/Akt and/or mitogen-activated protein kinase pathways.",
author = "Nancy Dumont and Bakin, {Andrei V.} and Arteaga, {Carlos L.}",
year = "2003",
month = "1",
day = "31",
doi = "10.1074/jbc.M204623200",
language = "English (US)",
volume = "278",
pages = "3275--3285",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "5",

}

TY - JOUR

T1 - Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells

AU - Dumont, Nancy

AU - Bakin, Andrei V.

AU - Arteaga, Carlos L.

PY - 2003/1/31

Y1 - 2003/1/31

N2 - Transforming growth factor-β (TGF-β) is a pleiotropic growth factor that plays a critical role in modulating cell growth, differentiation, and plasticity. There is increasing evidence that after cells lose their sensitivity to TGF-β-mediated growth inhibition, autocrine TGF-β signaling may potentially promote tumor cell motility and invasiveness. To understand the molecular mechanisms by which autocrine TGF-β may selectively contribute to tumor cell motility, we have generated MDA-MB-231 breast cancer cells stably expressing a kinase-inactive type II TGF-β receptor (TβRII-K277R). Our data indicate that TβRII-K277R is expressed, can associate with the type I TGF-β receptor, and block both Smad-dependent and -independent signaling pathways activated by TGF-β. In addition, wound closure and transwell migration assays indicated that the basal migratory potential of TβRII-K277R expressing cells was impaired. The impaired motility of TβRII-K277R cells could be restored by reconstituting TGF-β signaling with a constitutively active TGF-β type I receptor (ALK5TD) but not by reconstituting Smad signaling with Smad2/4 or Smad3/4 expression. In addition, the levels of ALK5TD expression sufficient to restore motility in the cells expressing TβRII-K277R were associated with an increase in phosphorylation of Akt and extracellular signal-regulated kinase 1/2 but not Smad2. These data indicate that different signaling pathways require different thresholds of TGF-β activation and suggest that TGF-β promotes motility through mechanisms independent of Smad signaling, possibly involving activation of the phosphatidylinositol 3-kinase/Akt and/or mitogen-activated protein kinase pathways.

AB - Transforming growth factor-β (TGF-β) is a pleiotropic growth factor that plays a critical role in modulating cell growth, differentiation, and plasticity. There is increasing evidence that after cells lose their sensitivity to TGF-β-mediated growth inhibition, autocrine TGF-β signaling may potentially promote tumor cell motility and invasiveness. To understand the molecular mechanisms by which autocrine TGF-β may selectively contribute to tumor cell motility, we have generated MDA-MB-231 breast cancer cells stably expressing a kinase-inactive type II TGF-β receptor (TβRII-K277R). Our data indicate that TβRII-K277R is expressed, can associate with the type I TGF-β receptor, and block both Smad-dependent and -independent signaling pathways activated by TGF-β. In addition, wound closure and transwell migration assays indicated that the basal migratory potential of TβRII-K277R expressing cells was impaired. The impaired motility of TβRII-K277R cells could be restored by reconstituting TGF-β signaling with a constitutively active TGF-β type I receptor (ALK5TD) but not by reconstituting Smad signaling with Smad2/4 or Smad3/4 expression. In addition, the levels of ALK5TD expression sufficient to restore motility in the cells expressing TβRII-K277R were associated with an increase in phosphorylation of Akt and extracellular signal-regulated kinase 1/2 but not Smad2. These data indicate that different signaling pathways require different thresholds of TGF-β activation and suggest that TGF-β promotes motility through mechanisms independent of Smad signaling, possibly involving activation of the phosphatidylinositol 3-kinase/Akt and/or mitogen-activated protein kinase pathways.

UR - http://www.scopus.com/inward/record.url?scp=0037474223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037474223&partnerID=8YFLogxK

U2 - 10.1074/jbc.M204623200

DO - 10.1074/jbc.M204623200

M3 - Article

C2 - 12421823

AN - SCOPUS:0037474223

VL - 278

SP - 3275

EP - 3285

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 5

ER -